Masoud Yousefi

1.1k total citations
35 papers, 880 citations indexed

About

Masoud Yousefi is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Masoud Yousefi has authored 35 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Medicine, 8 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Masoud Yousefi's work include Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Masoud Yousefi is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Amyotrophic Lateral Sclerosis Research (4 papers). Masoud Yousefi collaborates with scholars based in Iran, Canada and United States. Masoud Yousefi's co-authors include Neil R. Cashman, Edward Pokrishevsky, Leslie I. Grad, Helen Tremlett, V. Devonshire, Yinshan Zhao, Peter Rieckmann, Ian R. Mackenzie, Jing Wang and Ebrima Gibbs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Masoud Yousefi

32 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masoud Yousefi Iran 13 412 297 187 174 104 35 880
Avninder Singh India 16 37 0.1× 188 0.6× 84 0.4× 82 0.5× 18 0.2× 53 821
Maryam Izad Iran 16 26 0.1× 373 1.3× 64 0.3× 134 0.8× 40 0.4× 48 809
Marco Constante Canada 17 25 0.1× 347 1.2× 228 1.2× 37 0.2× 64 0.6× 25 867
Constantine D. Georgakopoulos Greece 16 45 0.1× 237 0.8× 58 0.3× 37 0.2× 22 0.2× 88 1.0k
Alejandra C. Cherñavsky Argentina 18 36 0.1× 151 0.5× 16 0.1× 70 0.4× 25 0.2× 35 1.0k
Victor Pham United States 11 32 0.1× 545 1.8× 84 0.4× 20 0.1× 67 0.6× 13 858
Yongfei Fang China 19 26 0.1× 679 2.3× 47 0.3× 66 0.4× 20 0.2× 40 1.4k
H. Atakan Ekiz United States 19 35 0.1× 553 1.9× 35 0.2× 53 0.3× 81 0.8× 38 1.0k
Tze-Tze Liu Taiwan 17 33 0.1× 459 1.5× 25 0.1× 20 0.1× 45 0.4× 38 887
Jin-Young Choi United States 11 18 0.0× 314 1.1× 21 0.1× 70 0.4× 77 0.7× 19 1.2k

Countries citing papers authored by Masoud Yousefi

Since Specialization
Citations

This map shows the geographic impact of Masoud Yousefi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Yousefi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Yousefi more than expected).

Fields of papers citing papers by Masoud Yousefi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Yousefi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Yousefi. The network helps show where Masoud Yousefi may publish in the future.

Co-authorship network of co-authors of Masoud Yousefi

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Yousefi. A scholar is included among the top collaborators of Masoud Yousefi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Yousefi. Masoud Yousefi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghazvini, Kiarash, et al.. (2024). Sustain-release lipid-liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL/6 mice. BMC Pharmacology and Toxicology. 25(1). 9–9. 2 indexed citations
2.
Yousefi, Masoud, et al.. (2022). Comparison of the Effect of Diode Laser Irradiation and Fluoride Varnish on Salivary Streptococcus mutans Bacterial Colonies Counts: A Randomized Controlled Clinical Trial. International Journal of Clinical Pediatric Dentistry. 15(S2). S239–S241. 1 indexed citations
5.
Namaei, Mohammad Hasan, et al.. (2021). High prevalence of multidrug-resistant non-fermentative Gram-negative bacilli harboring bla and bla metallo-beta-lactamase genes in Birjand, south-east Iran. Iranian Journal of Microbiology. 13(4). 470–479. 9 indexed citations
7.
Yousefi, Masoud, et al.. (2019). <p>The relation between zero-time pretransplant deceased donor renal biopsy and kidney transplant survival</p>. Research and Reports in Urology. Volume 11. 123–130. 1 indexed citations
8.
Zhao, Beibei, et al.. (2019). Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1. Vaccine. 37(35). 4920–4927. 21 indexed citations
10.
Namaei, Mohammad Hasan, et al.. (2017). First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran. Microbial Drug Resistance. 23(7). 879–884. 28 indexed citations
11.
Saeedi, Ramesh, Joshua A. Dubland, Masoud Yousefi, et al.. (2017). Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism. Annals of Hepatology. 16(2). 207–214. 11 indexed citations
12.
Pourmand, Mohammad Reza, et al.. (2015). Frequency and Antimicrobial Resistance Patterns of Methicillin-Resistant Staphylococcus aureus in Tehran. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Pourmand, Mohammad Reza, Masoud Yousefi, Seyed Alireza Salami, & Mohsen Amini. (2014). Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR.. PubMed. 52(6). 424–9. 29 indexed citations
14.
Yousefi, Masoud, et al.. (2014). Diet History Is a Reliable Predictor of Suboptimal Docosahexaenoic Acid Levels in Adult Patients with Phenylketonuria. JIMD Reports. 21. 97–102. 3 indexed citations
15.
Sayao, Ana‐Luiza, et al.. (2014). Health-related quality of life in patients with longstanding ‘benign multiple sclerosis’. Multiple Sclerosis and Related Disorders. 4(1). 31–38. 12 indexed citations
16.
Yousefi, Masoud, et al.. (2012). Minimum inhibitory concentration of ciprofloxacin in combination with hexahydroquinoline derivatives against Staphylococcus aureus. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Pourmand, Mohammad Reza, et al.. (2012). Molecular Typing of Clinical and Nasal Carriage Isolates of Staphylococcus Aureus by spa Gene Patterns. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 22(94). 27–34. 5 indexed citations
18.
Cashman, Neil R., Lei Tan, Charles Krieger, et al.. (2008). Pilot study of granulocyte colony stimulating factor (G‐CSF)‐mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle & Nerve. 37(5). 620–625. 64 indexed citations
19.
Yousefi, Masoud, et al.. (2007). A PATIENT WITH G6PD DEFICIENCY AND FALCIPARUM MALARIA (CASE REPORT). 2(1). 43–45. 1 indexed citations
20.
Griffin, Jennifer K., Linda A. Terry, R. Jackman, Masoud Yousefi, & Neil R. Cashman. (2007). Decreased cell surface prion protein in mouse models of prion disease. Neuroreport. 18(1). 1–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026